Systematic review of shared decision-making interventions for people living with chronic respiratory diseases
AC Barradell, C Gerlis, L Houchen-Wolloff… - BMJ open, 2023 - bmjopen.bmj.com
Objective Shared decision-making (SDM) supports patients to make informed and value-
based decisions about their care. We are developing an intervention to enable healthcare …
based decisions about their care. We are developing an intervention to enable healthcare …
The impact of decision tools during oncological consultation with lung cancer patients: A systematic review within the I3LUNG project
V Sebri, C Marzorati, P Dorangricchia… - Cancer …, 2024 - Wiley Online Library
Introduction To date, lung cancer is one of the most lethal diagnoses worldwide. A variety of
lung cancer treatments and modalities are available, which are generally presented during …
lung cancer treatments and modalities are available, which are generally presented during …
End-of-Life Health Resource Utilization for Limited English-Proficient Patients With Advanced Non–Small-Cell Lung Cancer
B Leung, SK Wong, C Ho - JCO Oncology Practice, 2022 - ascopubs.org
PURPOSE: Limited English-proficient (LEP) patients with non–small-cell lung cancer
(NSCLC) may receive less palliative care services and more likely to receive aggressive end …
(NSCLC) may receive less palliative care services and more likely to receive aggressive end …
A systematic review of shared decision-making interventions for people living with chronic
AC Barradell, C Gerlis, L Houchen-Wolloff, HL Bekker… - bmjopen.bmj.com
Supplementary Material 1: MEDLINE search strategy 1.((joint* or share* or sharing* or
informed*) adj3 (decision* or decid* 3 or choice*)). mp.[mp= title, abstract, original title, name …
informed*) adj3 (decision* or decid* 3 or choice*)). mp.[mp= title, abstract, original title, name …
[HTML][HTML] Best Practices: Education for Patients with Advanced NSCLC Treated with Immune Checkpoint Inhibitors
S Perkins - theoncologynurse.com
For many patients with non–small-cell lung cancer (NSCLC), immunotherapy is now
becoming the standard of care. Immunotherapy given as monotherapy or in combination …
becoming the standard of care. Immunotherapy given as monotherapy or in combination …